RNA Therapeutics Market Landscape: Industry Size, Trends, Key Players, and Industry Projections for 2028
In February 2023, Moderna, Inc. received authorization from Health Canada for its COVID-19 booster vaccine, mRNA-1273.214 (SpikevaxBivalent Original/Omicron).
View full press release